Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Glucagon-like peptide-1 receptor expression in the human eye

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The need for appropriate registration of pregnancy outcomes under newer oral glucose-lowering therapies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Inverted papilloma of the conjunctiva

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. KRAS mutations in the parental tumour accelerate in vitro growth of tumoroids established from colorectal adenocarcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A presentation of culture-positive corneal donors and the effect on clinical outcomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Orbital lymphoma

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Bruch's membrane allows unhindered passage of up to 2 μm latex beads in an in vivo porcine model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Josephine B Hebsgaard
  • Charles Pyke
  • Emre Yildirim
  • Lotte B Knudsen
  • Steffen Heegaard
  • Peter H Kvist
Vis graf over relationer

Semaglutide is a human glucagon-like peptide-1 (GLP-1) analogue that is in development for the treatment of type 2 diabetes. In the pre-approval cardiovascular outcomes trial SUSTAIN 6, semaglutide was associated with a significant increase in the risk of diabetic retinopathy (DR) complications vs placebo. GLP-1 receptor (GLP-1R) expression has previously been demonstrated in the retina in animals and humans; however, antibodies used to detect expression have been documented to be non-specific and fail to detect the GLP-1R using immunohistochemistry (IHC), a problem common for many G-protein coupled receptors. Using a validated GLP-1R antibody for IHC and in situ hybridization for GLP-1R mRNA in normal human eyes, GLP-1Rs were detected in a small fraction of neurons in the ganglion cell layer. In advanced stages of DR, GLP-1R expression was not detected at the protein or mRNA level. Specifically, no GLP-1R expression was found in the eyes of people with long-standing proliferative DR (PDR). In conclusion, GLP-1R expression is low in normal human eyes and was not detected in eyes exhibiting advanced stages of PDR.

OriginalsprogEngelsk
TidsskriftDiabetes, Obesity and Metabolism
Vol/bind20
Udgave nummer9
Sider (fra-til)2304-2308
Antal sider5
ISSN1462-8902
DOI
StatusUdgivet - sep. 2018

ID: 56469821